
The Potential Rise in the Price of Galectin Therapeutics Inc (GALT) following insiders activity
Galectin Therapeutics Inc’s recently made public that its Director ELDRED KARY acquired Company’s shares for reported $2925.0 on Jul 21
Galectin Therapeutics Inc’s recently made public that its Director ELDRED KARY acquired Company’s shares for reported $2925.0 on Jul 21
Cytek BioSciences Inc’s recent filing unveils that its Chief Financial Officer McCombe William D. acquired Company’s shares for reported $97300.0
In a filing, Huntsman Corp revealed its Chairman, President & CEO Huntsman Peter R acquired Company’s shares for reported $0.5
Solid Biosciences Inc’s filing revealed that its Director Kahn Clare acquired Company’s shares for reported $9924.0 on Mar 11 ’25.
Intapp Inc’s recently made public that its Chief Executive Officer HALL JOHN T unloaded Company’s shares for reported $0.47 million
Eaton Corporation plc’s recent filing unveils that its Officer LEONETTI OLIVIER acquired Company’s shares for reported $5.74 million on Aug
In a filing, Reynolds Consumer Products Inc revealed its Director Stangl Rolf acquired Company’s shares for reported $95580.0 on Jun
Hologic, Inc’s filing revealed that its Director Madaus Martin D acquired Company’s shares for reported $0.3 million on May 07
Kennedy-Wilson Holdings Inc’s recently made public that its CHAIRMAN AND CEO MCMORROW WILLIAM J acquired Company’s shares for reported $0.17
Moleculin Biotech Inc’s recent filing unveils that its Chief Financial Officer Foster Jonathan P. acquired Company’s shares for reported $100000.0